Over 30 Babies Mistakenly Receive Vaccines Not Approved For Children, Study Says

From 100PercentFedUp - READ ORIGINAL

Some media, including videos, may only be available to view at the original.  

The Defender reports at least 34 babies were mistakenly given the respiratory syncytial virus (RSV) vaccine, leading to at least one hospitalization.

The outlet cited a study published in Pediatrics.

“VAERS contains at least 1 report of a 27-day-old baby who died immediately after receiving Pfizer’s RSV vaccine, but that report was not included in the Pediatrics study,” Children’s Health Defense noted.

More than 30 Babies Mistakenly Vaccinated with Pfizer or GSK’s RSV Shots

VAERS contains at least 1 report of a 27-day-old baby who died immediately after receiving Pfizer’s RSV vaccine, but that report was not included in the Pediatrics study. https://t.co/3LonlhD4Ki

— Children’s Health Defense (@ChildrensHD) May 10, 2024

Per The Defender:

Researchers from the Centers for Disease Control and Prevention (CDC) analyzed data from the Vaccine Adverse Event Reporting System (VAERS) for the RSV vaccines, which are not approved for children.

The researchers found 27 reports of the Pfizer RSV vaccine (Abrysvo) and seven reports of the GSK RSV vaccine (Arexvy) mistakenly administered to children under 2 between Aug. 21, 2023, and March 18, 2024.

“While rare, vaccine administration errors are known to occur and may increase after a new vaccine or product is introduced,” Dr. Pedro Moro, lead author of the study, told MedPage Today.

Both vaccines were first approved in May 2023 for people ages 60 and older. Pfizer’s Abrysvo was approved in August 2023 for pregnant mothers during part of their third trimester, targeting RSV prevention in babies.

Thirty-one of the babies identified in the study who were mistakenly vaccinated were less than 8 months old. Seven reports described adverse health events including fevers, vomiting, coughing and injection site swelling.

One baby was hospitalized for cardiorespiratory arrest within 24 hours of receiving the GSK RSV vaccine. The baby had a history of congenital heart disease and was hospitalized at the time of the VAERS report.

Nearly three dozen babies and young children have received respiratory syncytial virus (RSV) vaccines, which are only approved for adults, according to a brief CDC report.

You think this is rare?

Vaccine injury is real. pic.twitter.com/HziboR2dmY

— Informed NJ Nurses (@InformedNJNurse) May 10, 2024

“Health care providers should not administer Pfizer or GSK RSV vaccines to infants and young children,” the study authors said, according to The Defender.

“Today’s report was published a few months after the CDC notified providers in January about 25 reports that Pfizer and GSK’s RSV vaccines had been mistakenly administered to infants and 128 reports that GSK’s vaccine — which is not approved for pregnant women — was mistakenly given to them,” the outlet stated.

I am so tired of finding CHILDREN in VAERS who are being HARMED by one vaccine or another and NOBODY does anything. Here’s problems with the RSV vax. IT WAS NOT APPROVED FOR CHILDREN.

39 have received it. Here’s one 5 yr-old who was given it INSTEAD OF THE FLU SHOT. THIS IS… pic.twitter.com/k87z1bilZW

— Julie4Butte5 (@julie4butte5) May 10, 2024

As 100 Percent Fed Up noted, “researchers for a maternal vaccine against respiratory syncytial virus (RSV) in infants stopped clinical trials because of an increased risk of preterm births.”

Maternal RSV Vaccine Stopped During Clinical Trials Due To Safety Concerns, FDA Approved Similar Vaccine From Different Manufacturer

From 100 Percent Fed Up:

“A vaccine given during pregnancy that prevents RSV in infants was about 66% effective at protecting against RSV-associated respiratory illness, and about 69% effective at protecting against severe disease, according to a study in the New England Journal of Medicine,” Chief Nerd wrote, citing JAMA Network.

“However, the researchers stopped the trial early because of an increased risk of preterm births. Despite the potential risks of maternal RSV vaccination, ‘it is essential to weigh this small risk against the proven benefits,’ the authors of a linked editorial wrote, adding that most of the preterm births occurred between 34 and 37 weeks,” Chief Nerd added.

The Defender noted the halted study was GlaxoSmithKline’s maternal respiratory syncytial virus (RSV) vaccine.

“GSK stopped developing a vaccine for pregnant women to protect newborns against syncytial virus (RSV) after identifying an increased risk of preterm births. Pfizer won approval of its nearly identical vaccine after the company said the increased rate of preterm births in its trials was statistically insignificant,” the outlet wrote.

“The results of this trial, in which enrollment was stopped early because of safety concerns, suggest that the risks of any and severe medically assessed RSV-associated lower respiratory tract disease among infants were lower with the candidate maternal RSV vaccine than with placebo but that the risk of preterm birth was higher with the candidate vaccine,” an article published in The New England Journal of Medicine stated.

“151 more preterm births and 10 more neonatal deaths in the vaccine group,” Chief Nerd noted.